Arthneeti
Sale is live|00:00:00
Tega Industries LtdQ4 FY27

Tega Industries Ltd Q4 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: 1,705P/E: 59.0Market Cap: ₹11.9K CrSector: Industrial Manufacturing

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Yes

Order

Yes

Capex

Yes

3 of 5 growth signals are positive.

Full analysis

Revenue guidance

Category 3
  • Tega Industries expects strong growth in Q4 FY26, supported by a robust order backlog, especially in equipment sales which are expected to ramp up after some quarter-to-quarter variability.
  • The full-year consumables segment growth for FY26 is anticipated around 8%, below the long-term 15% CAGR target; equipment business growth is forecasted at 28%-30%.
  • Long-term growth guidance of 15% CAGR in consumables remains intact, with a focus on double-digit group-level growth.
  • FY27 revenue guidance will be provided after finalizing budgets; Q4 momentum and operational improvements are expected to accelerate growth into FY27.
  • Mining industry growth drivers include increased throughput due to rising copper and gold prices, supporting higher consumable demand.
  • Post-Molycop acquisition, expansion in Europe, Latin America, and Australia will contribute to growth from FY27 onwards.
  • Overall, Tega is confident of sustained growth driven by strong order book, product mix, and global expansion.

Margin guidance

Category 3
  • Tega Industries expects strong full-year growth for FY26, with equipment business projected to grow 28%-30%, and consumables around 8%, leading to a decent double-digit group-level growth.
  • Long-term growth CAGR of 15% for the consumables segment remains intact.
  • EBITDA margins are expected to remain robust, with Q3 impacted by one-time expenses but underlying margins above 20%.
  • Q4 is anticipated to be strong, driven by execution of order backlog and equipment sales pushed from Q3.
  • The company is optimistic about sustaining growth through expansion in Europe, Latin America, and Australia from FY27 onward.
  • Financial closure of the Molycop acquisition expected by March 2026 will support growth, with funding secured via equity, debt, and internal accruals.
  • Guidance for FY27 will be provided post budget finalization, but growth momentum and profitability outlook remain positive.

3 more insights locked — sign up free to unlock

Fundraise plans

Yes
  • No immediate equity raise is planned beyond the Rs.1,700 crore raised in Round One for the Molycop acquisition.
  • The total investment in Molycop is around Rs.3,520 crores, financed through a mix of equity raised, internal accruals, and debt.
  • Currently, the company has sufficient funds and debt facilities to complete the transaction.
  • If needed, the company may consider additional equity fundraising in the future to reduce debt levels, but no concrete plans yet.
  • Debt financing has been increased as part of the capital structure for the Molycop acquisition, with borrowing facilities upsized accordingly.
  • A new instrument, OCRPS (Optionally Convertible Redeemable Preference Shares), is being used to remit funds into the Singapore subsidiary for the acquisition, providing financial structuring flexibility.
  • Any further capital raise or refinancing expenses related to the acquisition may occur post-transaction closure, expected by March 31, 2026, or in FY27.

Order book

Yes
  • As of December 31, 2025, Tega Industries reported an order book of approximately Rs. 1,114.02 crores.
  • Out of this, Rs. 810.2 crores worth of orders are executable within the next 12 months.
  • The company has a comfortable order backlog, particularly strong in equipment orders to be pushed in Q4.
  • Quarter-to-quarter variability exists due to deferment or preponement of orders.
  • Overall, the management advises focusing on full-year performance to smooth out such fluctuations.

Capex plans

Yes
  • The Chile CAPEX project is on track and expected to be ready for commercial production by Q2 FY27.
  • Alternate plants in Chile have been set up to avoid any capacity limitations during the interim period.
  • The company is making strategic investments in expanding presence across Europe, Latin America, and Australia, with customer trials and negotiations at advanced stages, expected to contribute meaningfully from FY27 onwards.
  • Regarding the Molycop acquisition, the company has increased its stake to 84% and is working on completing the transaction by March 31, 2026, with some potential spillover.
  • Financing for Molycop acquisition is through a mix of internal accruals, debt, and equity, with flexibility for further equity raise if needed.
  • Use of OCRPS instrument to remit funds into Tega Singapore entity for the Molycop transaction, allowing future restructuring flexibility.
  • No explicit new capex guidance provided; FY27 capex guidance to be revealed after budget finalization.

How does Tega Industries Ltd rank vs peers in Industrial Manufacturing?

Pro feature
1Tega Industries Ltd
Rev 3Mar 3

See full Industrial Manufacturing sector rankings

Want more stocks like Tega Industries Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio